David Hudson | Gay Star News | December 17, 2015
Dubbed ‘the most hated man in America’, the CEO of Turing Pharmaceuticals, Martin Shkreli, has been arrested on securities fraud charges.
Shkreli gained worldwide infamy in September when it was revealed that his company, which had recently acquired the rights to Daraprim, was to increase the price from $13.50 to $750 a pill.
The drug is used to treat toxoplasmosis, which commonly affects those with a compromised immune system, including people with HIV.
Prior to launching Turning Pharma., Shkreli, 32, was a hedge fund manager.
Turning Pharma. is not the first company that he has headed, and it’s his dealings over a previous company that have now got him into legal trouble.